We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHI icon
651
PLDT
PHI
$4.33B
$1.43M 0.01%
57,554
-7,193
-11% -$171K
CHA
652
DELISTED
China Telecom Corporation, LTD
CHA
$1.42M 0.01%
28,462
+25,451
+845% +$1.3M
FTI icon
653
TechnipFMC
FTI
$27.3B
$1.42M 0.01%
+73,697
New +$1.29M
RYAM icon
654
Rayonier Advanced Materials
RYAM
$610M
$1.41M 0.01%
+216,951
New +$2.26M
EFX icon
655
Equifax
EFX
$21.4B
$1.39M 0.01%
10,308
-2,860
-22% -$359K
LH icon
656
Labcorp
LH
$25.9B
$1.39M 0.01%
+9,328
New +$1.3M
BGS icon
657
B&G Foods
BGS
$286M
$1.38M 0.01%
+66,347
New +$1.53M
KURA icon
658
Kura Oncology
KURA
$850M
$1.37M 0.01%
+69,669
New +$1.16M
GHDX
659
DELISTED
Genomic Health, Inc.
GHDX
$1.37M 0.01%
+23,600
New +$1.4M
FLS icon
660
Flowserve
FLS
$10.2B
$1.37M 0.01%
+25,989
New +$1.28M
RP
661
DELISTED
RealPage, Inc.
RP
$1.37M 0.01%
23,226
+4,356
+23% +$264K
ETN icon
662
Eaton
ETN
$174B
$1.36M 0.01%
16,330
+12,978
+387% +$1.05M
CMBT
663
CMB.TECH NV
CMBT
$4.73B
$1.36M 0.01%
+143,871
New +$1.31M
JBLU icon
664
JetBlue
JBLU
$2.29B
$1.35M 0.01%
+73,218
New +$1.31M
PAG icon
665
Penske Automotive Group
PAG
$14.2B
$1.35M 0.01%
28,522
+22,938
+411% +$1.04M
BBIO icon
666
BridgeBio Pharma
BBIO
$16.5B
$1.35M 0.01%
+49,979
New +$1.36M
BCS icon
667
Barclays
BCS
$94.1B
$1.35M 0.01%
+180,601
New +$1.43M
MCHX icon
668
Marchex
MCHX
$79.7M
$1.35M 0.01%
286,357
+254,710
+805% +$1.22M
HOLI
669
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$1.34M 0.01%
70,626
+34,864
+97% +$676K
FRO icon
670
Frontline
FRO
$8.85B
$1.33M 0.01%
+166,617
New +$1.33M
SCOR icon
671
Comscore
SCOR
$109M
$1.33M 0.01%
12,871
+12,770
+12,644% +$2.73M
SFL icon
672
SFL Corp
SFL
$1.61B
$1.32M 0.01%
+105,692
New +$1.34M
WDAY icon
673
Workday
WDAY
$44.4B
$1.32M 0.01%
6,430
+5,832
+975% +$1.18M
GATX icon
674
GATX Corp
GATX
$6.27B
$1.32M 0.01%
+16,630
New +$1.26M
NGHC
675
DELISTED
National General Holdings Corp
NGHC
$1.31M 0.01%
57,123
+1,157
+2% +$27.6K
25 26
27
28 29

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.